Biogen (BIIB) EBITDA Margin (2009 - 2026)
Biogen (BIIB) recorded EBITDA Margin of 8.28% in Q3 2026, down 21.69 percentage points from 29.96% a year earlier and down 5.19 percentage points from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EBITDA Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Biogen's EBITDA Margin came in at 12.89% as of Sep 30, 2026, down 13.62 percentage points year-over-year; for FY2025, it came in at 23.62%, down 3.03 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -13.62 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 26.66% in FY2024 (+8.44 pp), 18.22% in FY2023 (-22.19 pp), 40.40% in FY2022 (+10.09 pp) and 30.31% in FY2021 (-6.94 pp).
- Quarterly EBITDA Margin has ranged from -0.64% in Q3 2023 to 59.47% in Q3 2022 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in four of the last eight quarters, with an average year-over-year change of -6.72 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 34.15 percentage points in Q4 2021, against a drop of 60.11 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 13.47% (Q2 2026), 23.49% (Q1 2026) and 6.33% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 42.49% |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 8.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8.28% |
| Jun 30, 2026 | 13.47% |
| Mar 31, 2026 | 23.49% |
| Dec 31, 2025 | 6.33% |
| Sep 30, 2025 | 29.96% |
| Jun 30, 2025 | 35.47% |
| Mar 31, 2025 | 20.34% |
| Dec 31, 2024 | 19.37% |
| Sep 30, 2024 | 25.70% |
| Jun 30, 2024 | 34.79% |
| Mar 31, 2024 | 26.73% |
| Dec 31, 2023 | 18.09% |
| Sep 30, 2023 | -0.64% |
| Jun 30, 2023 | 33.61% |
| Mar 31, 2023 | 22.35% |
| Dec 31, 2022 | 28.44% |
| Sep 30, 2022 | 59.47% |
| Jun 30, 2022 | 54.24% |
| Mar 31, 2022 | 29.77% |
| Dec 31, 2021 | 26.40% |
API Access
Biogen EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();